Benzinga | Jun 4, 2021 09:35AM EDT

NGM Biopharmaceuticals Publishes Clinical Trial Titled 'Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies' To ClinicalTrials.Gov

https://clinicaltrials.gov/ct2/show/NCT04913337